Table 6 Comparison of 1 year follow-up outcomes of the patients who were treated with nicardipine and labetalol
From: Hypertensive crisis in children: an experience in a single tertiary care center in Korea
Categories | Nicardipine (N = 23) | Labetalol (N = 18) | P-value |
|---|---|---|---|
Primary outcomes | |||
Mortality (%) | 6 (26.0) | 9 (50.0) | 0.191 |
Survivors (%) | 17 (74.0) | 9 (50.0) | |
Secondary outcomes (in survivors) | |||
Medication change | |||
Taking oral medication (%) | 10 (58.3) | 5 (55.6) | 1.000 |
No medication (%) | 7 (41.7) | 4 (44.4) | |
Clinical improvement | |||
Visual symptom† (%) | 0/2 (0.0) | 1/2 (50.0) | 1.000 |
Retinopathy (%) | 0/2 (0.0) | 1/2 (50.0) | 1.000 |
Seizure (%) | 5/5 (100.0) | 2/2 (100.0) | - |
Cr elevation (%) | 7/7 (100.0) | 5/6 (83.3) | 0.462 |
Hematuria or Proteinuria (%) | 4/8 (50.0) | 5/5 (100.0) | 0.105 |
LVH, RVH, BVH on ECG (%) | 1/2 (50.0) | 2/3 (66.7) | 1.000 |